Skip to main content
. 2018 Aug 21;13:2525–2532. doi: 10.2147/COPD.S167600

Table 1.

Characteristics of the study patients (N=121)

Characteristics COPD (n=65) ACO (n=56) P-value
Age (years) 72.3 (±9.8) 72.3 (±7.8) 0.608
Sex (M/F) 54/11 42/14 0.368
BMI (kg/m2) 23.0 (±3.7) 22.6 (±5.6) 0.679
Smoking status
 Current smoker 14 (21.5%) 12 (21.4%) 1.000
 Ex-smoker 48 (73.8%) 40 (71.4%)
 Pack-years 56.0 (±31.6) 46.4 (±30.0) 0.048
FVC (L) 3.15 (±0.80) 3.04 (±0.77) 0.464
FEV1 (L) 1.72 (±0.56) 1.55 (±0.51) 0.141
%FEV1 (%) 69.7 (±21.1) 64.9 (±17.6) 0.283
ICS use 8 (12.3%) 23 (41.1%) 0.0004
Comorbidity
 Hypertension 35 (53.8%) 31 (55.4%) 1.000
 Diabetes mellitus 16 (24.6%) 12 (21.4%) 0.829
 Cardiovascular diseasea 8 (12.3%) 6 (10.7%) 1.000
FeNO (ppb) 16.0 (12.0–20.0) 24.5 (14.0–39.5) 0.0012
Eo (cells/μL) 138.0 (90.0–207.5) 240.0 (127.5–310.0) 0.0142

Notes: Data are shown as medians (interquartile range) or means ± SD or number (%).

a

Cardiovascular disease includes coronary artery diseases such as angina and myocardial infarction.

Abbreviations: ACO, asthma–COPD overlap; BMI, body mass index; Eo, eosinophils; FeNO, fractional exhaled nitric oxide; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; ICS, inhaled corticosteroids.